Zdrowie i gospodarka · 16/03/2004

FDA Classifies Factor V Leiden DNA Mutation Detection Systems into Class II with Special Controls

The FDA has classified the Factor V Leiden DNA mutation detection systems into Class II with special controls, following a petition submitted under the Federal Food, Drug, and Cosmetic Act, in response to a need for a reasonable assurance of safety and effectiveness of the device.